Company: CMND
Filing Date: 2025-09-15
Form Type: POS AM
Source: 0001213900-25-087398
Chunk: 27

Company: Clearmind Medicine Inc.
Filing Date: 2025-09-15
Form: POS AM
Chunk 27
---
 of that proceeding. Each of our directors
and officers is deemed to have contracted with us on terms of the indemnity contained in our articles of association. In addition, we
may indemnify any other person in accordance with the BCBCA.

We also have entered and intend to enter into
separate indemnification agreements with our directors and executive officers, in addition to indemnification provided for in our articles
of association. These agreements, among other things, provide for indemnification of our directors and executive officers for expenses,
judgments, fines and settlement amounts incurred by such persons in any action or proceeding arising out of this person’s services
as a director or executive officer or at our request. We believe that these provisions in our articles of association and indemnification
agreements are necessary to attract and retain qualified persons as directors and executive officers.

The above description of the limitation of liability
and indemnification provisions of our articles of association of incorporation, and our indemnification agreements is not complete and
is qualified in its entirety by reference to these documents, each of which will be filed as an exhibit to this registration statement
to which this prospectus forms a part.

The limitation of liability and indemnification
provisions in our articles of association may discourage shareholders from bringing a lawsuit against our directors for breach of their
fiduciary duties. They may also reduce the likelihood of derivative litigation against directors and officers, even though an action,
if successful, might benefit us and our shareholders. A shareholder’s investment may be harmed to the extent we pay the costs of
settlement and damage awards against directors and officers pursuant to these indemnification provisions.

Insofar as indemnification for liabilities under
the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been
informed that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is therefore
unenforceable. There is no pending litigation or proceeding naming any of our directors or officers as to which indemnification is being
sought, nor are we aware of any pending or threatened litigation that may result in claims for indemnification by any director or officer.

Listing

Our Common Shares are listed on the Nasdaq
Capital Market under the symbol “CMND.” Our Common Shares also trade on the Frankfurt Stock Exchange under the symbol “CWY”.

Transfer Agent and Registrar

The transfer agent and registrar for our Common
Shares will be Computershare Limited.

<div align='center'>Comparison of